New Research Demonstrates Thymosin Beta 4's Potential Positive Effects on Alzheimer's Disease
RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("RegeneRx"), a clinical-stage drug development company focused on tissue protection, repair and regeneration), today announced that a new research...
www.regenerx.com